acetylcysteine has been researched along with dronabinol in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Haskó, G; Liaudet, L; Mackie, K; Mukhopadhyay, P; Pacher, P; Rajesh, M | 1 |
| Carroll, CB; Hanemann, CO; Zajicek, JP; Zeissler, ML | 1 |
| Rothbart, R; Stein, DJ | 1 |
| Laprevote, V; Rolland, B; Schwan, R; Schwitzer, T; Thome, J | 1 |
| Kalivas, PW; Spencer, S | 1 |
| Gorelick, DA | 1 |
| Gowing, L; Le Foll, B; Nielsen, S; Sabioni, P | 1 |
| Baker, NL; Gilmore, AK; Gray, KM; Hood, CO; McClure, EA; McRae-Clark, AL; Sonne, SC; Squeglia, LM; Tomko, RL | 1 |
4 review(s) available for acetylcysteine and dronabinol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacotherapy of trichotillomania (hair pulling disorder): an updated systematic review.
Topics: Acetylcysteine; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Dronabinol; Humans; Narcotic Antagonists; Olanzapine; Selective Serotonin Reuptake Inhibitors; Trichotillomania | 2014 |
Is There a Place for Off-Label Pharmacotherapy in Cannabis Use Disorder? A Review on Efficacy and Safety.
Topics: Acetylcysteine; Amines; Cannabidiol; Cyclohexanecarboxylic Acids; Dronabinol; Drug Combinations; Gabapentin; gamma-Aminobutyric Acid; Humans; Inappropriate Prescribing; Marijuana Abuse; Marijuana Smoking; Off-Label Use; Patient Safety; Practice Patterns, Physicians'; Psychotropic Drugs; Risk Assessment; Risk Factors; Treatment Outcome | 2015 |
Pharmacotherapies for cannabis dependence.
Topics: Acetylcysteine; Adult; Anticonvulsants; Antidepressive Agents; Buspirone; Dronabinol; Female; Humans; Male; Marijuana Abuse; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Young Adult | 2019 |
1 trial(s) available for acetylcysteine and dronabinol
| Article | Year |
|---|---|
Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder.
Topics: Acetylcysteine; Adult; Cannabis; Comorbidity; Depression; Double-Blind Method; Dronabinol; Female; Free Radical Scavengers; Humans; Male; Marijuana Abuse; Motivation; Treatment Outcome; Young Adult | 2020 |
7 other study(ies) available for acetylcysteine and dronabinol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells.
Topics: Acetylcysteine; Arachidonic Acids; Cell Death; Cell Line; Coronary Vessels; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Endothelial Cells; Humans; Mitogen-Activated Protein Kinases; Morpholines; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Reactive Oxygen Species; Receptor, Cannabinoid, CB1; Rimonabant; Signal Transduction | 2010 |
Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; Acetylcysteine; Cell Death; Cell Survival; Dose-Response Relationship, Drug; Dronabinol; Herbicides; Humans; Neurons; Neuroprotective Agents; Oxidative Stress; Paraquat; Parkinson Disease; Receptor, Cannabinoid, CB1; Tumor Cells, Cultured; Up-Regulation | 2012 |
Reply to: N-Acetylcysteine in Treatment of Substance Use Disorders.
Topics: Acetylcysteine; Dronabinol; Humans; Neuronal Plasticity; Nucleus Accumbens; Substance-Related Disorders | 2019 |
N-Acetylcysteine in Treatment of Substance Use Disorders.
Topics: Acetylcysteine; Dronabinol; Humans; Neuronal Plasticity; Nucleus Accumbens; Substance-Related Disorders | 2019 |